Modern Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
8,922
+6,886
+338% +$1.3M 0.02% 419
2026
Q1
$409K Sell
2,036
-324
-14% -$62.5K 0.01% 621
2025
Q4
$434K Buy
2,360
+400
+20% +$70.2K 0.01% 565
2025
Q3
$301K Buy
1,960
+120
+7% +$18.2K 0.01% 644
2025
Q2
$257K Sell
1,840
-53
-3% -$7.43K 0.01% 655
2025
Q1
$278K Buy
1,893
+109
+6% +$15.8K 0.01% 550
2024
Q4
$234K Buy
+1,784
New +$250K 0.01% 519

Other funds holding AZN

Modern Wealth Management's AZN Position: Q2 2026 in Review

Modern Wealth Management increased its AstraZeneca (AZN) stake by 338% in Q2 2026, buying an estimated $1.3M and bringing the position to 8,922 shares worth $1.69M. The position accounts for 0.02% of the portfolio, ranked #419.

Modern Wealth Management first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Modern Wealth Management held 8,922 shares of AstraZeneca worth $1.69M as of Q2 2026.
  • Modern Wealth Management bought 6,886 AstraZeneca shares in Q2 2026, an estimated $1.3M.
  • AstraZeneca made up 0.02% of Modern Wealth Management's portfolio in Q2 2026, its #419 holding.
  • Modern Wealth Management first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.